Cancers, Free Full-Text

Neuroblastoma is the most common extracranial solid pediatric tumor, with around 15% childhood cancer-related mortality. High-risk neuroblastomas exhibit a range of genetic, morphological, and clinical heterogeneities, which add complexity to diagnosis and treatment with existing modalities. Identification of novel therapies is a high priority in high-risk neuroblastoma, and the combination of genetic analysis with increased mechanistic understanding—including identification of key signaling and developmental events—provides optimism for the future. This focused review highlights several recent findings concerning chromosomes 1p, 2p, and 11q, which link genetic aberrations with aberrant molecular signaling output. These novel molecular insights contribute important knowledge towards more effective treatment strategies for neuroblastoma.

Join a FREE Breast Cancer Survivorship Program

Stand Up To Cancer - Cancer Research Charity

Pathology Outlines - Carcinoma-general

100% Cancer Free sticker — Perch Handmade

The Hallmarks of Cancer: Cell

Information and Resources about for Cancer: Breast, Colon, Lung, Prostate, Skin

Cancer Cells vs Normal Cells

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Hallmarks of Cancer: The Next Generation: Cell

Cancer Awareness Month Calendar & Ribbon Color

Clinical Genitourinary Cancer, Journal

Cancer - Wikipedia

Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization

Cancer